OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study
Zarin Abdullah, Ying Cui, Robert W. Platt, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004541-e004541
Open Access | Times Cited: 2

SGLT-2 inhibitors and dementia
Sung-Yun Tu, Shih‐Chieh Shao, Ching‐Hui Loh, et al.
BMJ (2024), pp. q1841-q1841
Open Access | Times Cited: 4

The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes
Stanley S. Schwartz, Mary E. Herman, May Thet Hmu Tun, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Åke Sjöholm, Louise Bennet, Peter M. Nilsson
Scandinavian Journal of Primary Health Care (2025), pp. 1-7
Open Access

Use of sodium‐glucose cotransporter‐2 inhibitors and risk of dementia: A population‐based cohort study
Lin Zhuo, Baixue Zhang, Yueqi Yin, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Managing dementia and diabetes in primary care settings
David L. Morris
Independent Nurse (2025) Vol. 2025, Iss. 2, pp. 22-25
Closed Access

Diabetes Typ 2: Beugen SGLT-2-Hemmer einer Demenz vor?

Allgemeinmedizin up2date (2025) Vol. 06, Iss. 01, pp. 8-8
Closed Access

Comparative risk of dementia in diabetic stroke patients prescribed SGLT2 vs. DPP-4 inhibitors: A propensity-matched retrospective cohort study
Pei-Chun Chiang, Cheng-Yang Hsieh, Sheng‐Feng Sung
Journal of Stroke and Cerebrovascular Diseases (2025), pp. 108276-108276
Open Access

Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Cardiovascular therapeutic targets of sodium-glucose co-transporter 2 (SGLT2) inhibitors beyond heart failure
Matteo Armillotta, Francesco Angeli, Pasquale Paolisso, et al.
Pharmacology & Therapeutics (2025) Vol. 270, pp. 108861-108861
Open Access

From geroscience to precision geromedicine: Understanding and managing aging
Guido Kroemer, Andrea B. Maier, Ana María Cuervo, et al.
Cell (2025) Vol. 188, Iss. 8, pp. 2043-2062
Closed Access

Comparative study of SGLT2 inhibitors and metformin: evaluating first-line therapies for dementia prevention in type 2 diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101655-101655
Closed Access

SGLT-2 inhibitors for diabetes may help prevent dementia, study finds
Zosia Kmietowicz
BMJ (2024), pp. q1875-q1875
Closed Access | Times Cited: 3

Antidiabetika könnten bei Demenz helfen

DMW - Deutsche Medizinische Wochenschrift (2024) Vol. 149, Iss. 21, pp. 1255-1255
Closed Access

Page 1

Scroll to top